Mo_0S_4[S_2P(OEt)_2]_4(H_2O)反应性能研究及Mo_3(μ-S)_3“类芳香”结构的设想

本文总结了对Mo～S簇合物Mo_3(μ3-S)(μ-S)_3(μ-dtp)(dtp)_3(H_2O)(I)(dtp=(EtO)_2PS_2~-)进行的配基置换,(μ-S)加成和Mo_2簇氧化等三种类型的十个反应。产物结构分析的结果揭示了反应的某些实验规律,从而为从一种已知簇合成一系列新簇的设计奠定了基础。如果假定“Mo_3(μ-S)_3”存在某种“类芳香”结构,则本研究和文献上的若干重要实验事实,可以获得合理的诠释。     

簇合物配基置换反应的研究——Mo3S4(μ-dtp)(η2-dtp)2(η1-dtp)(bpy)的合成与晶体结构

应用X-射线单晶衍射方法, 测定2,2-联吡啶(bpy)和簇合物MO_3S_4(μ-dtp)(dtp)_3(H_2O)(Ⅰ)反应产物褰峁埂ａ果? 产物为Mo_3S_4(μ-dtp)(η~2-dtp)_2(η~1-dtp)(bpy)(Ⅱ), 即联吡啶置换了簇合物(Ⅰ)中的端基(H_2O)和端基(dtp)中的一啮。簇合物(Ⅱ)晶体属三斜晶系。晶胞参数为:a=1.3638(3); b=1.3983(3); c=1.4699(2) nm, a=95.57(2)°, β=91.87(2)°, γ=117.40(2)°; V=2.4676 nm; Z=2; D_C=1.767 g·cm~(-3)。晶体的空间群为P1。最终偏离因子R=0.069, R_w=0.076。本文结合过去对簇合物(Ⅰ)进行的四种不同类型的置换反应的研究, 进行了必要的讨论。并指出本文中的反应是松散本位促进的配基置换反应。     

Crystallization and Preliminary Crystallographic Studies of Cucurmosin 2,a Ribosome-inactivating Protein from the Sarcocarp of Cucurbita moschata

Cucurmosin 2, a type 1 ribosome-inactivating protein （RIP） isolated from sarcocarp of Cucurbita moschata, has been crystallized by the vapor-diffusion method using PEG6000 as the precipitant. The crystals belong to the orthorhombic space group P212121, with unit cell parameters a = 55.853, b = 65.507, c = 91.754 А, and have one molecule per asymmetric unit. X-ray data have been collected to 1.8А, using a synchrotron source.     

Crystal Structures of Urokinase-type Plasminogen Activator in Complex with 4-（Aminomethyl） Benzoic Acid and 4-（Aminomethyl-phenyl）-methanol

Urokinase-type plasminogen activator （uPA） is a trypsin-like serine protease and plays a key role in several biological processes, including tissue remodeling, cell migration, and matrix degradation. The inhibitors of uPA have been shown to prevent the spread of metastasis and tumor growth, and accordingly uPA is widely recognized as a target for the treatment of cancer. In this work, we report the crystal structures of the complexes of uPA with its inhibitors： 4- （aminomethyl）-benzoic acid （AMBA） and 4-（aminomethyl-phenyl）-methanol （AMPM）, both at a resolution of 2.35 А. The inhibitory constants of these two inhibitors were measured by a chromogenic competitive assay, and it was found that AMBA is a better inhibitor for uPA （Ki = 2.68 mM） than AMPM （Ki = 13.99 mM）. The structural study shows that the binding mode of inhibitor AMBA on uPA is similar to that of AMPM on uPA, both docked into the active site S1 pocket of uPA. Structural details of these complexes are provided to explain the difference of inhibitory constants.     

簇合物配基置换反应的研究——Mo_3S_4(μ-dtp)(η~2-dtp)_2(η~1-dtp)(bpy)的合成与晶体结构

应用X-射线单晶衍射方法,测定2,2-联吡啶(bpy)和簇合物MO_3S_4(μ-dtp)(dtp)_3(H_2O)(Ⅰ)反应产物的晶体结构。结果表明,产物为Mo_3S_4(μ-dtp)(η~2-dtp)_2(η~1-dtp)(bpy)(Ⅱ),即联吡啶置换了簇合物(Ⅰ)中的端基(H_2O)和端基(dtp)中的一啮。簇合物(Ⅱ)晶体属三斜晶系。晶胞参数为:a=13.638(3);b=13.983(3);c=14.699(2),a=95.57(2)°,β=91.87(2)°,γ=117.40(2)°;V=2467.6~3;Z=2;D_C=1.767g·cm~(-3)。晶体的空间群为P1。最终偏离因子R=0.069,R_w=0.076。本文结合过去对簇合物(Ⅰ)进行的四种不同类型的置换反应的研究,进行了必要的讨论。并指出本文中的反应是松散本位促进的配基置换反应。     

电极表面Ag(δ+)-NH_3络合物的表面增强拉曼散射效应

本文采用氧化还原循环处理电极首次得到Ag/0.1mol L~(-1)NH_3+0.1mol L~(-1)NH_4Cl体系中吸附在银电极上氨分子的表面增强拉曼散射(SERS)效应。按氨分子在电极表面上的吸附量为每平方厘米8×10~(15)计算,增加因子为1.2×10~5.谱峰强度及位置随电极电位改变。吸附氨分子的SERS谱与Ag(NH_3)_2~+的正常拉曼光谱类似。本文结果表明电极表面上存在Ag(δ+)络合物,它可能是SERS效应的活性中心,用这个概念可较好地解释本文实验结果。通过谱图分析给出了Ag(δ+)表面络合物的可能结构模式。     

Preparation and Structure of a New Coagulation Factor XI Catalytic Domain for Drug Discovery

Human blood coagulation factor XI (FXI) is a key enzyme in the amplification phase of blood coagulation cascade,and is recognized as an important target for anti-coagulant deve-lopment in recent years.We designed a new mutant form of FXIa catalytic domain rhFXI 370～607 (N73Q-N113Q-C123S),and report here the facile preparation,protein crystallization,and crystal structure of this protein.We highlight a few unique structural features of FXIa after comparison with the trypsin family serine proteases at sequence and structural levels.This work provides a foundation to develop new small molecular FXIa inhibitors with increased potency and specificity.     

Maltose-binding Protein Improving the Crystallizability of C2 Domain of Human Coagulation Factor V

Human coagulation Factor V（FV）, together with Factor Xa, assembles to prothrombinase complex on activated cell surface, which converts prothrombin into thrombin, leading to fibrin deposition. The C2 domain of FV is believed to be a primary anchor for the assembly of pro- thrombinase on the cell surface, and was proposed as a target to intervene with pathological thrombotic events. We report here the crystal structure of the C2 domain of FV fused to maltose-binding protein（MBP）. The fusion tag of MBP is critical to generate the crystal for this study. There is no strong interaction between MBP and FVC2. The overall structure of FVC2 is similar to the previous FVC2 structures, suggesting the MBP fusion does not perturb the molecular structure of FVC2. This crystal form of FVC2 can be used for future study of molecular interaction between FVC2 and its inhibitors.     

三核钼簇合物的配基置换反应及{[Mo_3(μ_3—S)(μ—S)_3(dtp)_3(C_3H_4N_2)_3]~+(dtp)~-}·(CH_3)_2CO(Ⅰ)的合成和晶体结构

具有松散配位的三核钼簇合物[Mo_3(μ_3—S)(μ—S)_3(μ—dtp)(dtp)_3·(H_2O)](A)(dtp=S_2P(OC_2H_5)_2)和过量的咪唑反应时,(H_2O)配体和双啮桥基配体(dtp)可以同时被置换而形成标题化合物(Ⅰ)。晶体结构属三斜晶系,空间群P1。结构组成包括簇阳离子[Mo_3(μ_3—S)(μ—S)_3(dtp)_3·(C_3H_4N_2)_3],(dtp)阴离子及丙酮溶剂。簇阳离子具有近似C_3对称性,三个Mo原子基本上形成等边三角形,其Mo—Mo键长分别为2.763(1),2.762(1),和2.756(1),此簇合物是配体取代反应系列研究的产物之一,是由已知原子簇反应获得新型簇合物的一个例证。     

电极表面Ag(δ+)-NH3络合物的表面增强拉曼散射效应

本文采用氧化还原循环处理电极首次得到Ag/0.1 mol L~(-1)NH_3+0.1 mol L~(-1)NH_4Cl体系中吸附在银电极上氨分子的表面增强拉曼散射(SERS)效应。按氨分子在电极表面上的吸附量为每平方厘米8×10~(15)计算, 增加因子为1.2×10~5。谱峰强度及位置随电极电位改变。吸附氨分子的SERS谱与Ag(NH_3)_2~+的正常拉曼光谱类似。本文结果表明电极表面上存在Ag(δ+)络合物, 它可能是SERS效应的活性中心, 用这个概念可较好地解释本文实验结果。通过谱图分析给出了Ag(δ+)表面络合物的可能结构模式。